Observational studyScottish medical journal2020

Angiotensin converting enzyme inhibitors do not increase the risk of poor outcomes in COVID-19 disease. A multi-centre observational study.

Khurram Shahzad Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.